Effect of a Warming Mattress on Perioperative Hypothermia Following Cesarean Delivery

August 26, 2019 updated by: Mark Zakowski MD, Cedars-Sinai Medical Center

The primary aim of the current study will be to determine if the use of an underbody heating mattress during cesarean sections will decrease the incidence of postoperative hypothermia, defined as core temperature less than 36C, and if hypothermia occurs, time to normothermia. As part of the primary outcome the difference in the incidence of shivering, its severity, and need for treatment will be investigated. As a secondary goal other maternal perioperative outcomes will be studied i.e. estimated blood loss, change in hemoglobin level on the morning after surgery ie postop day 1, need for blood transfusion, rate of wound infections, length of hospital stay, maternal satisfaction, time to first breastfeeding, time to first 'skin to skin' contact. The relationship between maternal hypothermia and newborn outcomes of temperature and APGAR scores will also be evaluated.

Active preoperative and intraoperative warming may prevents inadvertent perioperative hypothermia and may be beneficial for pregnant patients undergoing cesarean delivery. The underbody warming mattress may be a step towards finding a suitable form of warming that is comfortable for awake patients, does not interfere with skin to skin contact and maternal-fetal bonding.

Study Overview

Status

Terminated

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Los Angeles, California, United States, 90048
        • Cedars Sinai

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • will be age >18 years,
  • singleton pregnancy >37 weeks,
  • neuraxial anesthesia,
  • healthy afebrile patients.

Exclusion Criteria:

  • • will be age >18 years,

    • singleton pregnancy >37 weeks,
    • neuraxial anesthesia,
    • healthy afebrile patients.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Underbody warmer on
Underbody warmer will be underneath the patient and turned on.
Use of VitaHeat underbody heating mattress will be used for the intervention arm to reduce hypothermia post operatively
Placebo Comparator: Underbody warmer off
Underbody warmer will be underneath the patient but not turned on.
Use of VitaHeat underbody heating mattress will be used for the intervention arm to reduce hypothermia post operatively

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Temperature
Time Frame: 15 minute intervals until normothermic, up to 45 minutes after admission Post Anesthesia Care Unit
Temperature at time of post anesthesia care unit admission
15 minute intervals until normothermic, up to 45 minutes after admission Post Anesthesia Care Unit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants With Shivering
Time Frame: 15 minute intervals until no shivering, up to 45 minutes after admission Post Anesthesia Care Unit
Shivering at time of post anesthesia care unit admission
15 minute intervals until no shivering, up to 45 minutes after admission Post Anesthesia Care Unit
Vitals: Heart Rate
Time Frame: Preop up to 45 minutes after admission Post Anesthesia Care Unit, 15 min intervals
Vitals: Heart Rate from preoperative through end of post anesthesia recovery unit
Preop up to 45 minutes after admission Post Anesthesia Care Unit, 15 min intervals
Blood Loss
Time Frame: Documented at the end of 2 hour surgical procedure
Estimated blood loss with and without warming
Documented at the end of 2 hour surgical procedure
Time to Neonatal Bonding
Time Frame: time from delivery to first maternal contact during the 2 hour surgical procedure
time to neonatal bonding as skin to skin
time from delivery to first maternal contact during the 2 hour surgical procedure
Thermal Comfort Visual Analog Scale
Time Frame: Preop up to 45 minutes after admission Post Anesthesia Care Unit, 15 min intervals
Thermal comfort visual analog scale with scores 0-100 with 50 being temperature comfort/neutral, 100 being hottest, 0 being cold
Preop up to 45 minutes after admission Post Anesthesia Care Unit, 15 min intervals
Vitals: Oxygen Saturation
Time Frame: Preop up to 45 minutes after admission Post Anesthesia Care Unit, 15 min intervals
Vitals: Oxygen Saturation from preoperative through end post anesthesia recovery unit
Preop up to 45 minutes after admission Post Anesthesia Care Unit, 15 min intervals
Vitals: Blood Pressure
Time Frame: Preop up to 45 minutes after admission Post Anesthesia Care Unit, 15 min intervals
Vitals: blood pressure as mean arterial pressure
Preop up to 45 minutes after admission Post Anesthesia Care Unit, 15 min intervals

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 5, 2017

Primary Completion (Actual)

January 1, 2018

Study Completion (Actual)

January 1, 2018

Study Registration Dates

First Submitted

July 6, 2016

First Submitted That Met QC Criteria

July 15, 2016

First Posted (Estimate)

July 20, 2016

Study Record Updates

Last Update Posted (Actual)

September 18, 2019

Last Update Submitted That Met QC Criteria

August 26, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Pro00039382

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Hypothermia

Clinical Trials on VitaHeat underbody heating mattress

3
Subscribe